Overview
Injective (INJ) and A (A) sit at different layers of the crypto stack. At current prices ($5.07 vs $0.063300), market leadership still favors Injective on capitalization, while 24h tape is led by Injective.
Quick winners
Full comparison
| Metric | INJ | A |
|---|---|---|
| Price | $5.07 | $0.063300 |
| Market Cap | $490.41M | $105.02M |
| FDV | — | — |
| Volume 24h | $2.62M | $187,969.19 |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 251.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.78% | +3.50% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | A |
|---|---|---|
| 1H | — | — |
| 24H | +3.42% | -0.32% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | A |
|---|---|---|
| RSI | 53.92 | 54.31 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 66.45 |
| ADX | 12.69 | 20.44 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.47 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 59.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight neutral conditions on INJ and bearish on A. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | INJ | A |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
A
Pros and cons
Pros of Injective
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
- Injective has an established coin page footprint on PEPS for continuous monitoring.
- Market-cap scale on Injective may dampen some idiosyncratic shocks versus smaller peers.
Cons of Injective
- When dominance narratives fade, Injective can lag hotter rotation names.
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
Pros of A
- Active volume bursts on A sometimes precede sharper tactical moves.
- A can offer higher relative beta when market attention rotates toward its niche.
Cons of A
- Trend failures on A often travel faster than on more established assets.
- Smaller book depth versus large caps can increase slippage for A.
- Incomplete fundamental coverage can hide operational or tokenomic risks.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
Comparing INJ and A begins with structure: capitalization, volume and rank. Present prints are $5.07 versus $0.063300. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate A-vs-INJ pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, Injective or A?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or A?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and A.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.